News
Hosted on MSN3mon
Passage Bio CFO sells shares worth $1,685Kathleen Borthwick, the Chief Financial Officer of Passage BIO, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company currently valued at $32.66 million, recently executed a series of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback